Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 4Stomach Neoplasms 2Cardiovascular Diseases 2Recurrence 1Pulmonary Embolism 1Pancreatic Neoplasms 1Neoplasms 1Lung Neoplasms 1Hemorrhage 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

acalabrutinib 2Social Determinants of Health 2Electrocardiography 2Echocardiography 2Blood Specimen Collection 2Aspirin 2zanubrutinib 1ribociclib 1phosphoribosylformylglycinamidine synthetase 1palbociclib 1ibrutinib 1glycidol 1abemaciclib 1Vascular Stiffness 1Testosterone 1Pulse Wave Analysis 1Noninvasive Prenatal Testing 1Magnetic Resonance Spectroscopy 1Health Services Needs and Demand 1Gonadotropin-Releasing Hormone 1Genetic Testing 1Exercise 1Eating 1Diet 1DNA 1Chemoradiotherapy 1Cardiovascular Agents 1Antineoplastic Agents 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Cardiovascular Diseases × Aspirin × Clear all
NCT03904732 2021-02-01

PEACOCS

Bayer

Completed
2,000,000 enrolled
Gastrointestinal

Cardiovascular Diseases, Hemorrhage, Colorectal Neoplasms

NCT03603366 2020-10-05

Study to Evaluate How Patients Regard the Benefits and Risks of Low-dose Aspirin for the Prevention of Heart and Blood Vessels Disease and for the Prevention of Cancer of the Colon and Rectum

Bayer

Completed
1,028 enrolled
Gastrointestinal

Cardiovascular Diseases, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡